Home Companies Myriad Genetics

Myriad Genetics

FDA Approves Myriad BRACAnalysis CDx for Lynparza in Metastatic Pancreatic Cancer
AstraZeneca

FDA Approves Myriad BRACAnalysis CDx for Lynparza in Metastatic Pancreatic Cancer

0
Myriad Wins Japanese Approval for BRACAnalysis to Assess Breast, Ovarian Cancer Risk
Breast Cancer

Myriad Wins Japanese Approval for BRACAnalysis to Assess Breast, Ovarian Cancer Risk

0
Myriad Shares Tumble 40%, as Company Lowers Guidance Following Revenue Shortfall
Industry News

Myriad Shares Tumble 40%, as Company Lowers Guidance Following Revenue Shortfall

0
FDA Approves Myriad’s myChoice CDx for Zejula’s Late-Line Ovarian Cancer Indication
Companies

FDA Approves Myriad’s myChoice CDx for Zejula’s Late-Line Ovarian Cancer Indication

0
Myriad Partners with LCPMH to Assess Clinical Utility of Prolaris Prostate Cancer Test
Industry News

Myriad Partners with LCPMH to Assess Clinical Utility of Prolaris Prostate Cancer Test

0

Trending

Autolus Confirms Positive Phase II Findings for Obe-cel CAR T-Cell Therapy

Autolus Confirms Positive Phase II Findings for Obe-cel CAR T-Cell Therapy

Study Defines Four Distinct Phenotypes of Long COVID

Study Defines Four Distinct Phenotypes of Long COVID

Rare Mutations Confer Risk of Common Diseases

Rare Mutations Confer Risk of Common Diseases

Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching

Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine